Ataiants Janna

Policing people who inject drugs: Evidence from Eurasia. Briefing Paper, IDPC, 2012

An estimated 3.7 million people inject drugs in Eurasia, representing the second highest prevalence of injecting drug use worldwide. Around one in four people who inject drugs in the region are living with HIV. From 2000 to 2010, the number of people living with HIV has increased by 250% in Eurasia, and the spread of HIV remains concentrated among people who inject drugs and their sexual partners. Drug injection is also one of the main drivers of hepatitis C in the region, with the prevalence among people who inject drugs ranging from 30% in Azerbaijan to 95% in Lithuania.

Policing people who inject drugs: Evidence from Eurasia, Ataiants, J., et al., IDPC, 2012

An estimated 3.7 million people inject drugs in Eurasia, representing the second highest prevalence of injecting drug use worldwide. Around one in four people who inject drugs in the region are living with HIV. From 2000 to 2010, the number of people living with HIV has increased by 250% in Eurasia, and the spread of HIV remains concentrated among people who inject drugs and their sexual partners. Drug injection is also one of the main drivers of hepatitis C in the region, with the prevalence among people who inject drugs ranging from 30% in Azerbaijan to 95% in Lithuania. 

A guide to developing and implementing overdose prevention programs in Eastern Europe and Central Asia, Ocheret, D., et. al., 2012

This guide was developed in response to the growing need among service providers working with drug users in Central and Eastern Europe and Central Asia to introduce overdose prevention work into their services. It summarizes best regional practices as a useful tool for non-governmental organizations working with people who use drugs and wanting to expand their services to introduce overdose prevention. The guide provides a set of concise recommendations on overdose programming based on lessons learned from colleagues in the region as well as additional information on overdose prevention, and an overview of the first pilot results that can serve as guidance in the planning, implementation and monitoring of new projects.